Clinical Trials Directory

Trials / Terminated

TerminatedNCT02740244

Effect of Intermittent ThetaBurst Stimulation in Treatment-resistant Bipolar Depression

Effects of Intermittent Theta Burst Stimulation Applied Over the Left Dorsolateral Prefrontal Cortex in Patients With Treatment-resistant Bipolar Depression

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Hôpital le Vinatier · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The aim is to evaluate the evaluate the clinical interest and the safety of repetitive transcranial magnetic stimulation (rTMS) delivered as intermittent Theta burst stimulation(iTBS) on severity of depression in patients with treatment-resistant bipolar disorder.

Detailed description

Methods: A double-blind randomized sham-controlled pilot study will be conducted in 40 patients with bipolar treatment-resistant depression receiving either active (n=20) or sham (n=20) iTBS over the left dorsolateral prefrontal cortex. Depression severity will be assessed by an investigator blinded to iTBS condition before and after 10 to 30 iTBS sessions depending on remission onset. Remission will be defined as Beck Depression Inventory, BDI score\<10. Objective/Hypothesis: The investigators hypothesized the superiority of active iTBS over sham ITBS

Conditions

Interventions

TypeNameDescription
DEVICEactive iTBSTranscranial magnetic stimulation. MagProX100 (MagVenture, Denmark) with a figure-eight coil (MCF-B65)
DEVICEsham iTBSTranscranial magnetic stimulation. MagProX100 (MagVenture, Denmark) with a sham figure-eight coil (MCF-P-B65)

Timeline

Start date
2011-01-01
Primary completion
2011-02-01
Completion
2015-01-01
First posted
2016-04-15
Last updated
2018-08-02

Source: ClinicalTrials.gov record NCT02740244. Inclusion in this directory is not an endorsement.